FSNIX
Price
$17.67
Change
-$0.07 (-0.39%)
Updated
Oct 7 closing price
Net Assets
4.68B
RLBAX
Price
$38.56
Change
-$0.09 (-0.23%)
Updated
Oct 7 closing price
Net Assets
266.1B
Interact to see
Advertisement

FSNIX vs RLBAX

Header iconFSNIX vs RLBAX Comparison
Open Charts FSNIX vs RLBAXBanner chart's image
Fidelity Advisor Asset Manager 60% I
Price$17.67
Change-$0.07 (-0.39%)
VolumeN/A
Net Assets4.68B
American Funds American Balanced R1
Price$38.56
Change-$0.09 (-0.23%)
VolumeN/A
Net Assets266.1B
FSNIX vs RLBAX Comparison Chart in %
View a ticker or compare two or three
VS
FSNIX vs. RLBAX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSNIX is a Buy and RLBAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 266B vs. FSNIX (4.68B). FSNIX pays higher dividends than RLBAX: FSNIX (1.86) vs RLBAX (1.10). FSNIX was incepted earlier than RLBAX: FSNIX (18 years) vs RLBAX (23 years). RLBAX (1.31) is less costly to investors than FSNIX (0.69). RLBAX is a more actively managed with annual turnover of: 44.00 vs. FSNIX (17.00). FSNIX has a lower initial minimum investment than RLBAX: FSNIX (0) vs RLBAX (250). FSNIX annual gain was more profitable for investors over the last year : 12.01 vs. RLBAX (9.12). FSNIX (38.59) and RLBAX (38.04) have equivalent 5 years return.
FSNIXRLBAXFSNIX / RLBAX
Total Expense Ratio0.691.3153%
Annual Report Gross Expense Ratio0.691.3153%
Fund Existence18 years23 years-
Gain YTD14.52513.770105%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets4.68B266B2%
Annual Yield % from dividends1.861.10169%
Returns for 1 year12.019.12132%
Returns for 3 years46.0247.9896%
Returns for 5 years38.5938.04101%
Returns for 10 years79.8268.72116%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WLY38.330.03
+0.09%
John Wiley & Sons
ROIV16.12-0.14
-0.86%
Roivant Sciences Ltd
PRLD1.44-0.02
-1.37%
Prelude Therapeutics
IVP0.98-0.03
-3.18%
Inspire Veterinary Partners Inc
GRRR19.99-0.68
-3.29%
Gorilla Technology Group